Clinical Relevance of the HD sEMG Signals in the Post-stroke Rehabilitation
ConditionStroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorAlain Kaelin
About this trial
The goal of this clinical trial is to learn about the WPM-SEMG-V2 device (Wireless Portable and Multi-Channel, WPM) designated to acquire high-density (HD) surface electromyography (sEMG) signals in healthy volunteers and post-stroke patients. The main objectives are: 1) to technically and clinically validate the WPM-SEMG-V2 device in healthy volunteers; 2) to demonstrate the clinical relevance of the HD sEMG signals to support the process of rehabilitation of post-stroke patients. Participants will be asked to perform simple exercises using the muscles of the hand or the leg in static or dynamic contractions while wearing the WPM-SEMG-V2 device.
Eligibility criteria
Qualifiers
Written Informed Consent
Female or male
18 years or older
Ability to understand the investigation
Disqualifiers
Any significant acute disease state
Skin disorders/allergies at the site of contact with the investigational device
History of skin disease
Known hypersensitivity or allergy to component of the investigational product (e.g. metal alloys) or other materials used (e.g., abrasive gel, foam with polystyrene markers)
Trial design
Treatments tested in this trial
- Acquisition of HD sEMG signals using the WPM-SEMG device
Treatment groups
40 Participants
are divided into 3 treatment groupsSponsors and collaborators
Alain Kaelin
Lead sponsor
Ente Ospedaliero Cantonale, Bellinzona
Sponsor institution
University of Applied Sciences and Arts of Southern Switzerland
Collaborator
Clinical Trial Unit Ente Ospedaliero Cantonale
Collaborator
Source ClinicalTrials.gov